Mirae Asset Global Investments’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2K | Buy |
2,280
+306
| +16% | +$2.3K | ﹤0.01% | 1417 |
|
|
2025
Q1 | $15.8K | Buy |
1,974
+34
| +2% | +$273 | ﹤0.01% | 1410 |
|
|
2024
Q4 | $23.3K | Sell |
1,940
-157
| -7% | -$1.89K | ﹤0.01% | 1400 |
|
|
2024
Q3 | $36K | Buy |
2,097
+376
| +22% | +$6.46K | ﹤0.01% | 1358 |
|
|
2024
Q2 | $29.4K | Sell |
1,721
-15,548
| -90% | -$266K | ﹤0.01% | 1331 |
|
|
2024
Q1 | $209K | Buy |
17,269
+3,134
| +22% | +$37.8K | ﹤0.01% | 2245 |
|
|
2023
Q4 | $144K | Buy |
14,135
+64
| +0.5% | +$652 | ﹤0.01% | 2396 |
|
|
2023
Q3 | $127K | Buy |
14,071
+114
| +0.8% | +$1.03K | ﹤0.01% | 2413 |
|
|
2023
Q2 | $150K | Sell |
13,957
-80
| -0.6% | -$861 | ﹤0.01% | 2421 |
|
|
2023
Q1 | $144K | Sell |
14,037
-188
| -1% | -$1.92K | ﹤0.01% | 2391 |
|
|
2022
Q4 | $150K | Buy |
14,225
+20
| +0.1% | +$211 | ﹤0.01% | 2366 |
|
|
2022
Q3 | $183K | Buy |
+14,205
| New | +$183K | ﹤0.01% | 2369 |
|